Associate Professor Diana Learoyd

Associate Professor
Medicine, Northern Clinical School

Telephone +61 2 9926 6774
Fax +61 2 9926 8523

Map

Selected grants

2008

  • Thyroid cancer - enhancing management and research outcomes; Learoyd D, Robinson B, Roach P, Delbridge L; Cancer Institute New South Wales/Infrastructure Grant.
  • Cross-talk between PPARg and MAP kinase pathways in thyroid cancer; Clifton-Bligh R, Au A, Learoyd D, Robinson B; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Learoyd, D., Robinson, B., Tacon, L. (2010). Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2. In J Larry Jameson and Leslie J De Groot (Eds.), Endocrinology 6th Edition, (pp. 90-91). United States: Elsevier Inc.

Journals

  • Thompson, A., Turner, R., Hayen, A., Ahmad, A., Jalaty, S., Learoyd, D., Sidhu, S., Delbridge, L., Yeh, M., Clifton-Bligh, R., Sywak, M. (2014). A Pre-operative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer. Thyroid, 24(4), 675-682. [More Information]
  • Kruijff, S., Petersen, J., Chen, P., Aniss, A., Clifton-Bligh, R., Sidhu, S., Delbridge, L., Gill, A., Learoyd, D., Sywak, M. (2014). Patterns of Structural Recurrence in Papillary Thyroid Cancer. World Journal of Surgery, 38, 653-659. [More Information]
  • Hibbert, E., Lambert, T., Carter, J., Learoyd, D., Twigg, S., Clarke, S. (2013). A randomized controlled pilot trial comparing the impact of access to clinical endocrinology video demonstrations with access to usual revision resources on medical student performance of clinical endocrinology skills. BMC Medical Education, 13(1), 1-10. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]
  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]
  • Popadich, A., Levin, O., Lee, J., Smooke-Praw, S., Ro, K., Fazel, M., Arora, A., Tolley, N., Palazzo, F., Learoyd, D., Sidhu, S., Delbridge, L., Sywak, M., et al (2011). A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 150(6), 1048-1057. [More Information]
  • O'Neill, C., Vaughan, L., Learoyd, D., Sidhu, S., Delbridge, L., Sywak, M. (2011). Management of Follicular Thyroid Carcinoma Should Be Individualised Based on Degree of Capsular and Vascular Invasion. European Journal of Surgical Oncology, 37(2), 181-185. [More Information]
  • Abraham, D., Low, T., Messina, M., Jackson, N., Gill, A., Chou, A., Delbridge, L., Learoyd, D., Robinson, B., Sidhu, S., Sywak, M. (2011). Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment. Annals of Surgical Oncology, 18, 219-225. [More Information]
  • O'Neill, C., Chan, C., Symons, J., Learoyd, D., Sidhu, S., Delbridge, L., Gill, A., Sywak, M. (2011). Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery. World Journal of Surgery, 35(1), 147-153. [More Information]
  • O'Neill, C., Spence, A., Logan, B., Suliburk, J., Soon, P., Learoyd, D., Sidhu, S., Sywak, M. (2010). Adrenal incidentalomas: Risk of adrenocortical carcinoma and clinical outcomes. Journal of Surgical Oncology, 102(5), 450-453. [More Information]
  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • McMullen, T., Learoyd, D., Williams, D., Sywak, M., Sidhu, S., Delbridge, L. (2010). Hyperparathyroidism in Pregnancy: Options for Localization and Surgical Therapy. World Journal of Surgery, 34(8), 1811-1816. [More Information]
  • Crawford, B., Cowell, C., Emder, P., Learoyd, D., Chua, E., Sinn, J., Jack, M. (2010). Iodine toxicity from soy milk and seaweed ingestion is associated with serious thyroid dysfunction. Medical Journal of Australia, 193(7), 413-415. [More Information]
  • O'Neill, C., Oucharek, J., Learoyd, D., Sidhu, S. (2010). Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer. The Oncologist, 15(2), 146-156. [More Information]
  • Neumann, H., Erlic, Z., Boedeker, C., Rybicki, L., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Benn, D., Robinson, B., Learoyd, D., et al (2009). Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Cancer Research, 69(8), 3650-3656.
  • Learoyd, D., Robinson, B. (2008). Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases? - Commentary. Nature clinical practice: Endocrinology and metabolism, 4(3), 132-133. [More Information]
  • Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Reeve, T., Delbridge, L. (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery, 144(6), 1038-1043. [More Information]
  • Low, T., Delbridge, L., Sidhu, S., Learoyd, D., Robinson, B., Roach, P., Sywak, M. (2008). Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Annals of Surgical Oncology, 15(10), 2827-2832. [More Information]
  • Learoyd, D., Robinson, B. (2008). Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer. Nature clinical practice. Endocrinology & metabolism, 5(1), 6-7. [More Information]
  • Lundgren, C., Delbridge, L., Learoyd, D., Robinson, B. (2007). Surgical approach to medullary thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia, 51(5), 818-824. [More Information]
  • Yan, W., Bautovich, G., Learoyd, D., Robinson, B. (2007). Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma. Clinical Nuclear Medicine, 32(5), 375-377. [More Information]
  • Warner, J., Nyholt, D., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2006). Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. Journal of Medical Genetics, 43(3), 1-7.
  • Gosnell, J., Sywak, M., Sidhu, S., Gough, I., Learoyd, D., Robinson, B., Delbridge, L. (2006). New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ Journal of Surgery, 76(7), 586-590. [More Information]
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]
  • Cardinal, J., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., et al (2005). A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics, 42(1), 69-74. [More Information]
  • Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
  • Learoyd, D., Robinson, B. (2005). Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery? Nature clinical practice: Endocrinology and metabolism, 1(2), 60-61.
  • Learoyd, D., Gosnell, J., Elston, M., Saurine, T., Richardson, A., Delbridge, L., Conaglen, J., Robinson, B. (2005). Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clinical Endocrinology, 63(6), 636-641. [More Information]
  • Alderazi, Y., Yeh, M., Robinson, B., Benn, D., Sywak, M., Learoyd, D., Delbridge, L., Sidhu, S. (2005). Phaeochromocytoma: current concepts. Medical Journal of Australia, 183(4), 201-204. [More Information]
  • Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2004). Genetic Testing In Familial Isolated Hyperparathyroidism: Unexpected Results And Their Implications. Journal of Medical Genetics, 41(3), 155-160.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2002). Detection of the PAX8-PPARy Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Dwight, T., Nelson, A., Theodosopoulos, G., Richardson, A., Learoyd, D., Philips, J., Delbridge, L., Zedenius, J., Teh, B., Larsson, C., Marsh, D., Robinson, B. (2002). Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparqathyroidism. The American Journal of Pathology: cellular and molecular biology of disease, 161(4), 1299-1306.
  • Villablanca, A., Wassif, W., Smith, T., Hoog, A., Vierimaa, O., Kassem, M., Dwight, T., Forsberg, L., Du, Q., Learoyd, D., Robinson, B., et al (2002). Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. European Journal of Endocrinology, 147(3), 313-322.
  • Learoyd, D., Messina, M., Robinson, B., Kjellman,, P., Weber, G., Hoog,, A., Wallin, G., Larsson, C., Zedenius, J. (2001). Expression of the RET proto-oncogene in papullary thyroid carcinoma and its correlation with clinical outcome. British Journal of Surgery, 88, 557-563.
  • Messina, M., Learoyd, D., Robinson, B., Both, G., Molloy, P. (2001). Gene therapy for endocrine tumors: strategies and progress. Current Opinion in Endocrinology, Diabetes and Obesity, 8, 35-40.

2014

  • Thompson, A., Turner, R., Hayen, A., Ahmad, A., Jalaty, S., Learoyd, D., Sidhu, S., Delbridge, L., Yeh, M., Clifton-Bligh, R., Sywak, M. (2014). A Pre-operative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer. Thyroid, 24(4), 675-682. [More Information]
  • Kruijff, S., Petersen, J., Chen, P., Aniss, A., Clifton-Bligh, R., Sidhu, S., Delbridge, L., Gill, A., Learoyd, D., Sywak, M. (2014). Patterns of Structural Recurrence in Papillary Thyroid Cancer. World Journal of Surgery, 38, 653-659. [More Information]

2013

  • Hibbert, E., Lambert, T., Carter, J., Learoyd, D., Twigg, S., Clarke, S. (2013). A randomized controlled pilot trial comparing the impact of access to clinical endocrinology video demonstrations with access to usual revision resources on medical student performance of clinical endocrinology skills. BMC Medical Education, 13(1), 1-10. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]

2012

  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]

2011

  • Popadich, A., Levin, O., Lee, J., Smooke-Praw, S., Ro, K., Fazel, M., Arora, A., Tolley, N., Palazzo, F., Learoyd, D., Sidhu, S., Delbridge, L., Sywak, M., et al (2011). A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery, 150(6), 1048-1057. [More Information]
  • O'Neill, C., Vaughan, L., Learoyd, D., Sidhu, S., Delbridge, L., Sywak, M. (2011). Management of Follicular Thyroid Carcinoma Should Be Individualised Based on Degree of Capsular and Vascular Invasion. European Journal of Surgical Oncology, 37(2), 181-185. [More Information]
  • Abraham, D., Low, T., Messina, M., Jackson, N., Gill, A., Chou, A., Delbridge, L., Learoyd, D., Robinson, B., Sidhu, S., Sywak, M. (2011). Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment. Annals of Surgical Oncology, 18, 219-225. [More Information]
  • O'Neill, C., Chan, C., Symons, J., Learoyd, D., Sidhu, S., Delbridge, L., Gill, A., Sywak, M. (2011). Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery. World Journal of Surgery, 35(1), 147-153. [More Information]

2010

  • O'Neill, C., Spence, A., Logan, B., Suliburk, J., Soon, P., Learoyd, D., Sidhu, S., Sywak, M. (2010). Adrenal incidentalomas: Risk of adrenocortical carcinoma and clinical outcomes. Journal of Surgical Oncology, 102(5), 450-453. [More Information]
  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • McMullen, T., Learoyd, D., Williams, D., Sywak, M., Sidhu, S., Delbridge, L. (2010). Hyperparathyroidism in Pregnancy: Options for Localization and Surgical Therapy. World Journal of Surgery, 34(8), 1811-1816. [More Information]
  • Crawford, B., Cowell, C., Emder, P., Learoyd, D., Chua, E., Sinn, J., Jack, M. (2010). Iodine toxicity from soy milk and seaweed ingestion is associated with serious thyroid dysfunction. Medical Journal of Australia, 193(7), 413-415. [More Information]
  • Learoyd, D., Robinson, B., Tacon, L. (2010). Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2. In J Larry Jameson and Leslie J De Groot (Eds.), Endocrinology 6th Edition, (pp. 90-91). United States: Elsevier Inc.
  • O'Neill, C., Oucharek, J., Learoyd, D., Sidhu, S. (2010). Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer. The Oncologist, 15(2), 146-156. [More Information]

2009

  • Neumann, H., Erlic, Z., Boedeker, C., Rybicki, L., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Benn, D., Robinson, B., Learoyd, D., et al (2009). Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Cancer Research, 69(8), 3650-3656.

2008

  • Learoyd, D., Robinson, B. (2008). Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases? - Commentary. Nature clinical practice: Endocrinology and metabolism, 4(3), 132-133. [More Information]
  • Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Reeve, T., Delbridge, L. (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery, 144(6), 1038-1043. [More Information]
  • Low, T., Delbridge, L., Sidhu, S., Learoyd, D., Robinson, B., Roach, P., Sywak, M. (2008). Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Annals of Surgical Oncology, 15(10), 2827-2832. [More Information]
  • Learoyd, D., Robinson, B. (2008). Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer. Nature clinical practice. Endocrinology & metabolism, 5(1), 6-7. [More Information]

2007

  • Lundgren, C., Delbridge, L., Learoyd, D., Robinson, B. (2007). Surgical approach to medullary thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia, 51(5), 818-824. [More Information]
  • Yan, W., Bautovich, G., Learoyd, D., Robinson, B. (2007). Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma. Clinical Nuclear Medicine, 32(5), 375-377. [More Information]

2006

  • Warner, J., Nyholt, D., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2006). Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. Journal of Medical Genetics, 43(3), 1-7.
  • Gosnell, J., Sywak, M., Sidhu, S., Gough, I., Learoyd, D., Robinson, B., Delbridge, L. (2006). New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ Journal of Surgery, 76(7), 586-590. [More Information]
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]

2005

  • Cardinal, J., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., et al (2005). A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics, 42(1), 69-74. [More Information]
  • Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
  • Learoyd, D., Robinson, B. (2005). Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery? Nature clinical practice: Endocrinology and metabolism, 1(2), 60-61.
  • Learoyd, D., Gosnell, J., Elston, M., Saurine, T., Richardson, A., Delbridge, L., Conaglen, J., Robinson, B. (2005). Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clinical Endocrinology, 63(6), 636-641. [More Information]
  • Alderazi, Y., Yeh, M., Robinson, B., Benn, D., Sywak, M., Learoyd, D., Delbridge, L., Sidhu, S. (2005). Phaeochromocytoma: current concepts. Medical Journal of Australia, 183(4), 201-204. [More Information]

2004

  • Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2004). Genetic Testing In Familial Isolated Hyperparathyroidism: Unexpected Results And Their Implications. Journal of Medical Genetics, 41(3), 155-160.

2003

  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.

2002

  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2002). Detection of the PAX8-PPARy Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Dwight, T., Nelson, A., Theodosopoulos, G., Richardson, A., Learoyd, D., Philips, J., Delbridge, L., Zedenius, J., Teh, B., Larsson, C., Marsh, D., Robinson, B. (2002). Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparqathyroidism. The American Journal of Pathology: cellular and molecular biology of disease, 161(4), 1299-1306.
  • Villablanca, A., Wassif, W., Smith, T., Hoog, A., Vierimaa, O., Kassem, M., Dwight, T., Forsberg, L., Du, Q., Learoyd, D., Robinson, B., et al (2002). Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. European Journal of Endocrinology, 147(3), 313-322.

2001

  • Learoyd, D., Messina, M., Robinson, B., Kjellman,, P., Weber, G., Hoog,, A., Wallin, G., Larsson, C., Zedenius, J. (2001). Expression of the RET proto-oncogene in papullary thyroid carcinoma and its correlation with clinical outcome. British Journal of Surgery, 88, 557-563.
  • Messina, M., Learoyd, D., Robinson, B., Both, G., Molloy, P. (2001). Gene therapy for endocrine tumors: strategies and progress. Current Opinion in Endocrinology, Diabetes and Obesity, 8, 35-40.

To update your profile click here. For support on your academic profile contact .